Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
Go back to Illumina and Labcorp expand collaboration to broaden access to precision oncology testing| Illumina, Inc. (NASDAQ: ILMN) | Delayed: 161.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.38 | 52 Week High | $196.47 | |||
| Open | $161.38 | 52 Week Low | $127.10 | |||
| Day High | $161.38 | P/E | 179.31 | |||
| Day Low | $161.38 | EPS | $0.90 | |||
| Volume | 1,174 | |||||
| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 254.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $254.43 | 52 Week High | $141.32 | |||
| Open | $254.43 | 52 Week Low | $97.79 | |||
| Day High | $254.43 | P/E | 40.71 | |||
| Day Low | $254.43 | EPS | $6.25 | |||
| Volume | 89 | |||||
